Empagliflozin/linagliptin

Drugs used in diabetes | Endocrine System

Items (National)
9,333
NHS Cost
£557.0K
Practices
720
Avg per Practice
13

Overview

Empagliflozin/linagliptin is prescribed by 720 GP practices across England. In the last 12 months, 9,333 items were prescribed at a total cost of £557,020 to the NHS. It is classified under BNF Chapter Endocrine System, Section Drugs used in diabetes.

Monthly Prescribing Trend

No monthly data available.

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
N 1,156 8 145 +1,011.5% ▲
E 576 22 26 +101.5% ▲
RM 367 9 41 +213.8% ▲
UB 354 8 44 +240.8% ▲
SS 323 9 36 +176.2% ▲
B 273 14 20 +50.0% ▲
WS 271 4 68 +421.5% ▲
ST 211 6 35 +170.8% ▲
S 207 9 23 +76.9% ▲
OL 191 8 24 +83.8% ▲
CO 190 4 48 +265.4% ▲
BN 155 3 52 +297.7% ▲
DN 153 8 19 +46.9% ▲
RH 146 1 146 +1,023.1% ▲
M 132 8 17 +26.9% ▲
CV 131 10 13 +0.8% vs avg
HU 131 5 26 +101.5% ▲
WD 127 2 64 +388.5% ▲
LE 121 3 40 +210.0% ▲
TN 113 6 19 +44.6% ▲

BNF Classification

Related drugs in this section

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.